page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Category:

  • Respiratory

Description:

  • Antiasthmatic, bronchodilator, vasopressor, sympathomimetic

Indications:

  • Mild or transient episodes of heart block and Stokes-Adams attacks (except when caused by ventricular tachycardia or fibrillation)

  • Cardiac arrest (until electric shock or pacemaker is available)

  • Bronchospasm occurring during anesthesia, asthma, chronic bronchitis, or emphysema

  • Hypovolemic and septic shock, low cardiac output states, CHF, cardiogenic shock

Contraindications:

  • Tachydysrhythmias, tachycardia or heart block caused by digitalis intoxication

  • Ventricular dysrhythmias requiring inotropic therapy, angina pectoris

Precautions:

  • Pregnancy category C

  • Hypovolemia, coronary artery disease, coronary insufficiency

  • Diabetes, hyperthyroidism

Adverse Reactions (Side Effects):

  • CNS: anxiety, dizziness, headache, mild tremors, nervousness, weakness

  • CV: angina, hypertension, hypotension, palpitations, tachycardia, tachydysrhythmias, ventricular dysrhythmias

  • GI: nausea, vomiting

  • RESP: pulmonary edema

  • SKIN: flushing of skin, sweating

Dosage:

Administered orally (inhalation via solution and aerosol), intravenously, intramuscularly, subcutaneously

  • Adult:            

    • Bronchospasm: 

      • MDI 1-2 puffs 4-6 times daily

      • NEB 0.25-0.5ml of a 1% solution diluted in 2-3ml normal saline or 0.25% and 0.5% undiluted, treatment may be repeated up to 5 times daily

    • Dysrhythmia/heart block: 

      • IV 0.02-0.06mg (1-3ml of 1:50,000 dilution) bolus, followed by subsequent doses of 0.01-0.2mg (0.5-10ml op 1:50,000 dilution)

      • IV INF 5 mcg/min initially, titrate to desired response, usual range 2-20 mcg/min

      • IM 0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of 0.02-1mg (0.1-5ml of 1:5,000 dilution)

      • SC 0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of 0.15-0.2mg (0.75-1ml of 1:5,000 dilution)

      • IC 0.02mg (0.1ml of 1:5,000 dilution)

    • Shock: 

      • IV INF 0.5-5 mcg/min (0.25-2.5ml of 1:500,000 dilution), titrate to patient response

  • Child:            

    • Bronchospasm: 

      • MDI 1-2 puffs up to 6 times daily; NEB 0.01 ml/kg of 1% solution; minimum dose 0.1 ml, max dose 0.5ml diluted in 2-3ml normal saline

    • Shock: 

      • IV INF 0.05-2 mcg/kg/min, rate (ml/hr) = dose (mcg/kg/min) X weight (kg) X 60 min/hr divided by concetration (mcg/ml)

 

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site